10-QPeriod: Q2 FY2022

ECOLAB INC. Quarterly Report for Q2 Ended Jun 30, 2022

Filed August 4, 2022For Securities:ECL

Summary

Ecolab Inc. (ECL) reported its second quarter 2022 financial results, showing a 13% increase in reported net sales year-over-year, reaching $3.58 billion. This growth was driven by a combination of pricing actions and volume increases across its segments, with fixed currency sales up 17%. Despite topline growth, reported operating income saw a 5% decrease to $425.8 million, and net income attributable to Ecolab declined 1% to $308.3 million. This was primarily due to increased cost of sales, particularly delivered product costs, which more than offset pricing gains. The company is navigating a challenging macroeconomic environment characterized by inflation and supply chain disruptions, which are impacting its gross margins. The company maintained a strong balance sheet with total assets of $21.2 billion and total liabilities of $14.0 billion. Ecolab continues to return capital to shareholders through dividends and share repurchases, demonstrating a commitment to shareholder value. While facing inflationary pressures, Ecolab's diversified business model and strategic pricing initiatives are expected to help mitigate these challenges moving forward.

Financial Highlights

53 data points
Beta

Revenue

$3.58B

38.2% Gross Margin

Net Income

$308.30M

8.6% Net Margin

EPS (Diluted)

$1.08

Total Assets

$21.16B

Cash & Equivalents

$124.90M

Free Cash Flow

$153.60M

Financial Statements
Beta
Revenue$3.58B
Cost of Revenue$2.21B
Gross Profit$1.37B
SG&A Expenses$940.10M
Operating Income$425.80M
Interest Expense$57.30M
Net Income$308.30M
EPS (Basic)$1.08
EPS (Diluted)$1.08
Shares Outstanding (Basic)285.10M
Shares Outstanding (Diluted)286.60M

Key Highlights

  • 1Reported net sales increased 13% to $3.58 billion in Q2 2022 compared to Q2 2021.
  • 2Fixed currency sales grew 17% year-over-year, indicating strong underlying business performance.
  • 3Reported operating income decreased 5% to $425.8 million, impacted by rising cost of sales.
  • 4Net income attributable to Ecolab was $308.3 million, a slight decrease of 1% year-over-year.
  • 5Diluted EPS remained flat at $1.08 for the quarter.
  • 6The company is actively managing its capital structure, with $8.8 billion in total debt and $124.9 million in cash and cash equivalents as of June 30, 2022.
  • 7Ecolab experienced significant growth in its Global Healthcare & Life Sciences segment, with fixed currency sales up 37%, largely due to the Purolite acquisition.

Frequently Asked Questions

The decrease in operating income was primarily driven by an increase in the cost of sales, specifically delivered product costs, which more than offset the benefits of accelerating pricing and volume increases. This is a common challenge faced by many companies in the current inflationary environment.

Ecolab is implementing pricing actions to mitigate the impact of higher delivered product costs. They are also focused on operational efficiencies and new business wins across their segments to help offset these inflationary pressures and supply chain disruptions.

The Global Healthcare & Life Sciences segment showed strong growth, with fixed currency sales up 37%. This growth was significantly influenced by the Purolite acquisition. Excluding acquisition impacts, sales were flat, with growth in Life Sciences offset by modest declines in Healthcare. The company expects continued pricing and new business growth in Life Sciences to drive future performance.

Ecolab continues to return capital to shareholders through dividend payments and share repurchases. During the first six months of 2022, the company paid $300 million in dividends and repurchased $403 million of its shares.